fluorouracil and lead
fluorouracil has been researched along with lead in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Briggs, L; Parry, N; Recher, L; Whitescarver, J | 1 |
| Hackenthal, E; Schmidt-Gayk, H; Seyberth, HW | 1 |
| Blanquicett, C; Buchsbaum, DJ; Carpenter, MD; Chhieng, DC; Diasio, RB; Eloubeidi, M; Johnson, MR; Russo, S; Saif, MW; Sellers, JC; Vickers, SM | 1 |
| Hermans, JJ; Hop, WC; Incrocci, L; Jeekel, J; Kazemier, G; Morak, MJ; van Dekken, H; van der Gaast, A; van Eijck, CH | 1 |
| Al-Dhfyan, A; Al-Omar, MA; Bhat, MA; Khan, AA; Naglah, AM | 1 |
Trials
1 trial(s) available for fluorouracil and lead
| Article | Year |
|---|---|
Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Common Bile Duct Neoplasms; Cycloleucine; Disease Progression; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Lead; Male; Middle Aged; Mitoxantrone; Pancreatic Neoplasms; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Sulfides; Treatment Outcome | 2008 |
Other Studies
4 other study(ies) available for fluorouracil and lead
| Article | Year |
|---|---|
Lead-positive nuclear structures and their behavior under the effect of various drugs.
Topics: Adenosine; Cell Line; Cell Nucleolus; Cell Nucleus; Cycloheximide; Dactinomycin; Deoxyadenosines; Female; Fluorouracil; Histological Techniques; Humans; Lead; Methods; Microscopy, Electron; Pepsin A; Puromycin; Ribonucleases; Staining and Labeling; Thymidine; Trypsin; Uterine Cervical Neoplasms | 1972 |
Toxicity, clearance and distribution of endotoxin in mice as influenced by actinomycin D, cycloheximide, -amanitin and lead acetate.
Topics: Acetates; Animals; Azathioprine; Chromium Isotopes; Cycloheximide; Cyclophosphamide; Dactinomycin; Endotoxins; Escherichia coli; Fluorouracil; Injections, Intraperitoneal; Injections, Intravenous; Lead; Lethal Dose 50; Male; Methotrexate; Mice; Mycotoxins; Protein Biosynthesis; RNA; Salmonella; Time Factors | 1972 |
Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.
Topics: 5'-Nucleotidase; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Celecoxib; Colorectal Neoplasms; Combined Modality Therapy; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Humans; Immunohistochemistry; Intestinal Mucosa; Ki-67 Antigen; Lead; Mice; Mice, Nude; Neoplasm Transplantation; Pancreas; Pancreatic Neoplasms; Pyrazoles; RNA, Messenger; Sulfonamides; Xenograft Model Antitumor Assays | 2005 |
Lead Optimization of 2-Cyclohexyl-N-[(Z)-(3-methoxyphenyl/3-hydroxyphenyl) methylidene]hydrazinecarbothioamides for Targeting the HER-2 Overexpressed Breast Cancer Cell Line SKBr-3.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA, Neoplasm; Female; Fluorouracil; Guanidines; Humans; Lead; Molecular Structure; Protein Kinase Inhibitors; Receptor, ErbB-2 | 2015 |